Search Results
Search for other papers by Sihan Lv in
Google Scholar
PubMed
Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China
Search for other papers by Xinchen Qiu in
Google Scholar
PubMed
Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China
Search for other papers by Jian Li in
Google Scholar
PubMed
Search for other papers by Jinye Liang in
Google Scholar
PubMed
Search for other papers by Weida Li in
Google Scholar
PubMed
Search for other papers by Chao Zhang in
Google Scholar
PubMed
Search for other papers by Zhen-Ning Zhang in
Google Scholar
PubMed
Search for other papers by Bing Luan in
Google Scholar
PubMed
levels during the fasted state ( Longuet et al . 2008 ). PPARα, a master transcription factor that regulates expression of fatty acid oxidation genes such as Aox , Cpt1a and Medium-chain acyl-CoA dehydrogenase ( Mcad ), serves as the major target of
Search for other papers by Sung-Soo Park in
Google Scholar
PubMed
Search for other papers by Yeon-Joo Lee in
Google Scholar
PubMed
Search for other papers by Sooyeon Song in
Google Scholar
PubMed
Search for other papers by Boyong Kim in
Google Scholar
PubMed
Search for other papers by Hyuno Kang in
Google Scholar
PubMed
Search for other papers by Sejong Oh in
Google Scholar
PubMed
Search for other papers by Eungseok Kim in
Google Scholar
PubMed
(SREBP-1c) and peroxisome proliferator-activated receptor α (PPARα), are important for the transcriptional regulation of these hepatic functions ( Kersten et al . 2000 , Horton et al . 2002 ). SREBP-1c is initially synthesized as an inactive
Instituto Bioingeniería, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Laboratorio de Medicina Regenerativa and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Universidad Miguel Hernández de Elche, Elche 03202, Alicante, Spain
Search for other papers by Ana B Ropero in
Google Scholar
PubMed
Instituto Bioingeniería, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Laboratorio de Medicina Regenerativa and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Universidad Miguel Hernández de Elche, Elche 03202, Alicante, Spain
Search for other papers by Pablo Juan-Picó in
Google Scholar
PubMed
Search for other papers by Alex Rafacho in
Google Scholar
PubMed
Instituto Bioingeniería, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Laboratorio de Medicina Regenerativa and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Universidad Miguel Hernández de Elche, Elche 03202, Alicante, Spain
Search for other papers by Esther Fuentes in
Google Scholar
PubMed
Search for other papers by F Javier Bermúdez-Silva in
Google Scholar
PubMed
Search for other papers by Enrique Roche in
Google Scholar
PubMed
Instituto Bioingeniería, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Laboratorio de Medicina Regenerativa and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Universidad Miguel Hernández de Elche, Elche 03202, Alicante, Spain
Search for other papers by Ivan Quesada in
Google Scholar
PubMed
Search for other papers by Fernando Rodríguez de Fonseca in
Google Scholar
PubMed
Instituto Bioingeniería, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Laboratorio de Medicina Regenerativa and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Universidad Miguel Hernández de Elche, Elche 03202, Alicante, Spain
Search for other papers by Angel Nadal in
Google Scholar
PubMed
superfamily of ligand activated transcription factors ( Robinson-Rechavi et al . 2003 ). PPARs, particularly PPARα and γ, are regulators of lipid metabolism because they act as lipid sensors. Therefore, PPAR ligands represent important pharmaceutical agents
Search for other papers by Sarah Teillon in
Google Scholar
PubMed
Search for other papers by German A Calderon in
Google Scholar
PubMed
Search for other papers by Maribel Rios in
Google Scholar
PubMed
increases susceptibility to type 2 diabetes, liver cirrhosis, and cardiovascular disease. Recently, the transcription factor peroxisome proliferator-activated receptor α (Pparα or Ppara as listed in the MGI Database) and its downstream target, fibroblast
Search for other papers by Anna G Holmes in
Google Scholar
PubMed
Search for other papers by Jose L Mesa in
Google Scholar
PubMed
Diabetes and Metabolism Division, School of Medical Sciences, St Vincent's Institute and Department of Medicine, CSIRO Molecular and Health Technologies, Department of Physiology, Cellular and Molecular Metabolism Laboratory, Baker Heart Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia
Search for other papers by Bronwyn A Neill in
Google Scholar
PubMed
Search for other papers by Jason Chung in
Google Scholar
PubMed
Search for other papers by Andrew L Carey in
Google Scholar
PubMed
Search for other papers by Gregory R Steinberg in
Google Scholar
PubMed
Diabetes and Metabolism Division, School of Medical Sciences, St Vincent's Institute and Department of Medicine, CSIRO Molecular and Health Technologies, Department of Physiology, Cellular and Molecular Metabolism Laboratory, Baker Heart Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia
Search for other papers by Bruce E Kemp in
Google Scholar
PubMed
Search for other papers by Robert J Southgate in
Google Scholar
PubMed
Search for other papers by Graeme I Lancaster in
Google Scholar
PubMed
Search for other papers by Clinton R Bruce in
Google Scholar
PubMed
Search for other papers by Matthew J Watt in
Google Scholar
PubMed
Search for other papers by Mark A Febbraio in
Google Scholar
PubMed
(PPAR) γ coactivator-1 α (PGC-1α) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-PPARδ and anti-PPARα (Research Diagnostics, Concord, MA, USA) were obtained from Cell Signaling (Beverly, MA, USA). Plasma analysis Plasma IL-6 was measured by
Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford Churchill Hospital, Oxford, UK
Search for other papers by C G Walker in
Google Scholar
PubMed
Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford Churchill Hospital, Oxford, UK
Search for other papers by M C Sugden in
Google Scholar
PubMed
Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford Churchill Hospital, Oxford, UK
Search for other papers by G F Gibbons in
Google Scholar
PubMed
Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford Churchill Hospital, Oxford, UK
Search for other papers by M J Holness in
Google Scholar
PubMed
activation of peroxisome proliferator-activated receptor (PPAR) γ ( Guan et al. 2002 , Picard & Auwerx 2002 , Tordjman et al. 2003 , Li et al. 2005 ), a lipogenic transcription factor. Contrasting with the role of PPARγ, PPARα acts as a
Search for other papers by Alessandro Antonelli in
Google Scholar
PubMed
Search for other papers by Silvia Martina Ferrari in
Google Scholar
PubMed
Search for other papers by Silvia Frascerra in
Google Scholar
PubMed
Search for other papers by Ilaria Ruffilli in
Google Scholar
PubMed
Search for other papers by Cinzia Pupilli in
Google Scholar
PubMed
Search for other papers by Giampaolo Bernini in
Google Scholar
PubMed
Search for other papers by Stefano Sellari-Franceschini in
Google Scholar
PubMed
Search for other papers by Stefania Gelmini in
Google Scholar
PubMed
Search for other papers by Ele Ferrannini in
Google Scholar
PubMed
Search for other papers by Poupak Fallahi in
Google Scholar
PubMed
peroxisome proliferator-activated receptors α (PPARα (PPARA)), PPARγ (PPARG), and PPARδ (PPARD) are ligand-activated nuclear receptors with a wide range of effects on metabolism, cell proliferation, and differentiation ( Michalik et al . 2006 ). In addition
Search for other papers by Masaya Takeda in
Google Scholar
PubMed
Search for other papers by Fumio Otsuka in
Google Scholar
PubMed
Search for other papers by Hiroyuki Otani in
Google Scholar
PubMed
Search for other papers by Kenichi Inagaki in
Google Scholar
PubMed
Search for other papers by Tomoko Miyoshi in
Google Scholar
PubMed
Search for other papers by Jiro Suzuki in
Google Scholar
PubMed
Search for other papers by Yukari Mimura in
Google Scholar
PubMed
Search for other papers by Toshio Ogura in
Google Scholar
PubMed
Search for other papers by Hirofumi Makino in
Google Scholar
PubMed
Introduction Peroxisome proliferator-activated receptors (PPARs) that include PPARα , PPARβ /δ, and PPARγ belong to the family of nuclear hormone receptors, which are related to thyroid hormone, retinoic acid, androgen, and estrogen
Search for other papers by Mary C Sugden in
Google Scholar
PubMed
Search for other papers by Paul W Caton in
Google Scholar
PubMed
Search for other papers by Mark J Holness in
Google Scholar
PubMed
by post-translation modifications (deacetylation catalyzed by the NAD + -regulated protein deacetylase SIRT) of both PPARα (PPARA as listed in the HUGO Database) and the PGC-1s, and propose that SIRT1 may lie at the heart of a regulatory loop
Search for other papers by Luana Lopes Souza in
Google Scholar
PubMed
Search for other papers by Aline Cordeiro in
Google Scholar
PubMed
Search for other papers by Lorraine Soares Oliveira in
Google Scholar
PubMed
Search for other papers by Gabriela Silva Monteiro de Paula in
Google Scholar
PubMed
Search for other papers by Larissa Costa Faustino in
Google Scholar
PubMed
Search for other papers by Tania Maria Ortiga-Carvalho in
Google Scholar
PubMed
Search for other papers by Karen Jesus Oliveira in
Google Scholar
PubMed
Search for other papers by Carmen Cabanelas Pazos-Moura in
Google Scholar
PubMed
metabolism genes ( Jump 2008 , Jump et al . 2008 ). The hypolipidemic effect of the FO has been explained by several mechanisms. Most of the FO effects were exerted via PPARα ( Sugiyama et al . 2008 ) and other hepatic transcriptional factors such as